CBS 2019
CBSMD教育中心
中 文

推荐文献

Abstract

Recommended Article

Disrupting Fellow Education Through Group Texting: WhatsApp in Fellow Education? A Novel Familial Cardiac Arrhythmia Syndrome with Widespread ST-Segment Depression Qualitative and Mixed Methods Provide Unique Contributions to Outcomes Research Can the Vanishing Stent Reappear? Fix the Technique, or Fix the Device? Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial Impact of Artificial Intelligence on Interventional Cardiology: From Decision-Making Aid to Advanced Interventional Procedure Assistance Limitations of Repeat Revascularization as an Outcome Measure Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial

Clinical Trial2018 Oct 27. [Epub ahead of print]

JOURNAL:J Am Coll Cardiol. Article Link

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial

M Szarek, HD White, PH Steg, ODYSSEY OUTCOMES Committees and Investigators. Keywords: Alirocumab; acute coronary syndrome; total events

FuLL TEXT PDF